These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16340982)
21. Evidence that the nonsense-mediated mRNA decay pathway participates in X chromosome dosage compensation in mammals. Yin S; Deng W; Zheng H; Zhang Z; Hu L; Kong X Biochem Biophys Res Commun; 2009 Jun; 383(3):378-82. PubMed ID: 19364502 [TBL] [Abstract][Full Text] [Related]
22. Making structural sense of nonsense-mediated decay. Lykke-Andersen J Nat Struct Mol Biol; 2004 Apr; 11(4):305-6. PubMed ID: 15048104 [No Abstract] [Full Text] [Related]
30. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy. Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280 [TBL] [Abstract][Full Text] [Related]
31. Inactivation of NMD increases viability of sup45 nonsense mutants in Saccharomyces cerevisiae. Chabelskaya S; Gryzina V; Moskalenko S; Le Goff C; Zhouravleva G BMC Mol Biol; 2007 Aug; 8():71. PubMed ID: 17705828 [TBL] [Abstract][Full Text] [Related]
32. Execution of nonsense-mediated mRNA decay: what defines a substrate? Rebbapragada I; Lykke-Andersen J Curr Opin Cell Biol; 2009 Jun; 21(3):394-402. PubMed ID: 19359157 [TBL] [Abstract][Full Text] [Related]
33. Failsafe nonsense-mediated mRNA decay does not detectably target eIF4E-bound mRNA. Matsuda D; Hosoda N; Kim YK; Maquat LE Nat Struct Mol Biol; 2007 Oct; 14(10):974-9. PubMed ID: 17873884 [TBL] [Abstract][Full Text] [Related]
34. Expression levels of Protocadherin-alpha transcripts are decreased by nonsense-mediated mRNA decay with frameshift mutations and by high DNA methylation in their promoter regions. Kaneko R; Kawaguchi M; Toyama T; Taguchi Y; Yagi T Gene; 2009 Feb; 430(1-2):86-94. PubMed ID: 19038318 [TBL] [Abstract][Full Text] [Related]
35. Nonsense-mediated decay: linking a basic cellular process to human disease. Bashyam MD Expert Rev Mol Diagn; 2009 May; 9(4):299-303. PubMed ID: 19435450 [No Abstract] [Full Text] [Related]
36. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia. Chen XW; Mo QH; Li Q; Zeng R; Xu XM Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Al-Allawi NA; Jubrael JM; Hughson M Hemoglobin; 2006; 30(4):479-86. PubMed ID: 16987803 [TBL] [Abstract][Full Text] [Related]
38. Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Isken O; Maquat LE Genes Dev; 2007 Aug; 21(15):1833-56. PubMed ID: 17671086 [TBL] [Abstract][Full Text] [Related]
39. A new insertion mutation in the beta-globin gene [codons 45/46 (+A)] resulting in a beta-thalassemia minor phenotype. Cornut G; Weng X; Robin L; Lavoie C; Marchand S; Soulières D Hemoglobin; 2007; 31(3):393-5. PubMed ID: 17654079 [TBL] [Abstract][Full Text] [Related]
40. Diversity of the 5' beta-globin haplotype of four beta-thalassemia mutations in the Mexican population. Morales KR; Magaña MT; Ibarra B; Perea FJ Hemoglobin; 2009; 33(1):66-71. PubMed ID: 19205976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]